Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer...
<p><a href="https://www.learningwithlowell.com/6268-2/" rel="nofollow">Source</a></p>

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer...
<p><a href="https://www.learningwithlowell.com/6268-2/" rel="noopener noreferrer">Source</a></p>

Share targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222

Sign up to save your podcasts

targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222

targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222